Real-world Outcomes and Tolerability of JAK Inhibitors in Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Single-center Retrospective Study

In this dataset, we have provided supplementary information for the study titled "Real-world Outcomes and Tolerability of JAK Inhibitors in Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Single-center Retrospective Study" The supplementary materials include supplementary Figures and tables. A detailed description is provided below: FIG2:Scores of UCT from baseline to week 12 after the first JAKi administration FIG3:Scores of CU-Q2oL from baseline to week 12 after the first JAKi administration Materials and Methods TABLE II | The demographic, clinical, and immunological features of responders and nonresponders in CSU patients. TABLE III | The demographic, clinical, and immunological features of early/late responders and nonresponders in CSU patients.